{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:51:12Z","timestamp":1791093072556,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.jconrel.2014.01.022","type":"journal-article","created":{"date-parts":[[2014,2,2]],"date-time":"2014-02-02T11:33:49Z","timestamp":1391340829000},"page":"18-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Interferon gamma peptidomimetic targeted to hepatic stellate cells ameliorates acute and chronic liver fibrosis in vivo"],"prefix":"10.1016","volume":"179","author":[{"given":"Ruchi","family":"Bansal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"De Ruiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaas","family":"Poelstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2014.01.022_bb0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tox.2008.06.013","article-title":"Hepatic fibrosis \u2014 overview","volume":"254","author":"Friedman","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.jconrel.2014.01.022_bb0010","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2014.01.022_bb0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-2007-991517","article-title":"Hepatic fibrogenesis","volume":"27","author":"Guo","year":"2007","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0020","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2014.01.022_bb0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-6143.2005.01143.x","article-title":"Antifibrotic agents for liver disease","volume":"6","author":"Albanis","year":"2006","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-5926-6-7","article-title":"Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options","volume":"6","author":"Gressner","year":"2007","journal-title":"Comp. Hepatol."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0035","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/hep.20476","article-title":"Stellate cells: a moving target in hepatic fibrogenesis","volume":"40","author":"Friedman","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2014.01.022_bb0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0045","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jhep.2011.04.008","article-title":"Targeted therapy of liver fibrosis\/cirrhosis and its complications","volume":"55","author":"Poelstra","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0050","first-page":"275","article-title":"Gamma-interferon: physiology and speculation on its role in medicine","volume":"6","author":"Bonnem","year":"1987","journal-title":"J. Biol. Response Modif."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0055","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1517\/14712598.6.10.1051","article-title":"Interferon-gamma 1b for the treatment of idiopathic pulmonary fibrosis","volume":"6","author":"Bouros","year":"2006","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0060","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jhep.2007.06.022","article-title":"Interferon-gamma exacerbates liver damage, the hepatic progenitor cell response and fibrosis in a mouse model of chronic liver injury","volume":"47","author":"Knight","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0065","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1046\/j.1523-1755.1999.00775.x","article-title":"Interferon-gamma inhibits experimental renal fibrosis","volume":"56","author":"Oldroyd","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0070","first-page":"438","article-title":"Phase I study of recombinant gamma-interferon (rIFN-gamma)","volume":"7","author":"Boman","year":"1988","journal-title":"J. Biol. Response Modif."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0075","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(09)60551-1","article-title":"Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial","volume":"374","author":"King","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2014.01.022_bb0080","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJM199910213411703","article-title":"A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis","volume":"341","author":"Ziesche","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jconrel.2011.05.027","article-title":"PEGylation improves pharmacokinetic profile, liver uptake and efficacy of interferon gamma in liver fibrosis","volume":"154","author":"Bansal","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.01.022_bb0090","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1021\/mp200263q","article-title":"Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis","volume":"8","author":"Bansal","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0095","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/hep.24395","article-title":"Novel engineered targeted interferon-gamma blocks hepatic fibrogenesis in mice","volume":"54","author":"Bansal","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2014.01.022_bb0100","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1158\/1535-7163.MCT-11-0758","article-title":"Selective targeting of interferon gamma to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growth","volume":"11","author":"Bansal","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0105","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.1021\/bi036213t","article-title":"Signal transduction mechanism of a peptide mimetic of interferon-gamma","volume":"43","author":"Subramaniam","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2014.01.022_bb0110","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1006\/bbrc.1994.2375","article-title":"The C-terminus of IFN gamma is sufficient for intracellular function","volume":"203","author":"Szente","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0115","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1101\/gad.1653708","article-title":"Role of platelet-derived growth factors in physiology and medicine","volume":"22","author":"Andrae","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0120","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/labinvest.2008.71","article-title":"Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury","volume":"88","author":"Borkham-Kamphorst","year":"2008","journal-title":"Lab. Invest."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0125","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.510270238","article-title":"Purification of rat hepatic stellate cells by side scatter-activated cell sorting","volume":"27","author":"Geerts","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2014.01.022_bb0130","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0006-2952(03)00445-3","article-title":"The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue","volume":"66","author":"Beljaars","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0135","doi-asserted-by":"crossref","first-page":"G245","DOI":"10.1152\/ajpgi.2000.279.2.G245","article-title":"Metalloproteinases and their inhibitors in liver fibrosis","volume":"279","author":"Arthur","year":"2000","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0140","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2007.02.003","article-title":"Expression of MMPs and TIMPs in liver fibrosis \u2014 a systematic review with special emphasis on anti-fibrotic strategies","volume":"46","author":"Hemmann","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0150","doi-asserted-by":"crossref","first-page":"20918","DOI":"10.1073\/pnas.0911509106","article-title":"Acute in vivo exposure to interferon-gamma enables resident brain dendritic cells to become effective antigen presenting cells","volume":"106","author":"Gottfried-Blackmore","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0155","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/hep.510230538","article-title":"Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis","volume":"23","author":"Baroni","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2014.01.022_bb0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1749-6632.2009.05069.x","article-title":"Clinical use of interferon-gamma","volume":"1182","author":"Miller","year":"2009","journal-title":"Ann.N.Y.Acad.Sci."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0165","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jhep.2006.09.014","article-title":"IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads","volume":"46","author":"Weng","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0170","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.4049\/jimmunol.178.7.4576","article-title":"IFN mimetic as a therapeutic for lethal vaccinia virus infection: possible effects on innate and adaptive immune responses","volume":"178","author":"Ahmed","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0175","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1128\/CVI.00021-06","article-title":"The gamma interferon (IFN-gamma) mimetic peptide IFN-gamma (95\u2013133) prevents encephalomyocarditis virus infection both in tissue culture and in mice","volume":"13","author":"Mujtaba","year":"2006","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0180","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1242\/jcs.00528","article-title":"The role of IFNgamma nuclear localization sequence in intracellular function","volume":"116","author":"Ahmed","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0185","first-page":"71","article-title":"Gamma interferon signaling: insights to development of interferon mimetics","volume":"52","author":"Johnson","year":"2006","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0190","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2010.03.018","article-title":"A novel approach to deliver anticancer drugs to key cell types in tumors using a PDGF receptor-binding cyclic peptide containing carrier","volume":"145","author":"Prakash","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.01.022_bb0195","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1124\/jpet.107.132290","article-title":"Cellular targeting of the apoptosis-inducing compound gliotoxin to fibrotic rat livers","volume":"324","author":"Hagens","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0200","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/hep.23419","article-title":"Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats","volume":"51","author":"Moreno","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2014.01.022_bb0205","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nbt1396","article-title":"Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone","volume":"26","author":"Sato","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0210","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1124\/jpet.111.179143","article-title":"Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice","volume":"337","author":"van Beuge","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0215","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1073\/pnas.96.13.7569","article-title":"Activation of erythropoietin receptor in the absence of hormone by a peptide that binds to a domain different from the hormone binding site","volume":"96","author":"Naranda","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2014.01.022_bb0220","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1126\/science.281.5374.257","article-title":"A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor","volume":"281","author":"Tian","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2014.01.022_bb0225","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.284.5416.974","article-title":"Discovery of a small molecule insulin mimetic with antidiabetic activity in mice","volume":"284","author":"Zhang","year":"1999","journal-title":"Science"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914000510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914000510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T19:04:46Z","timestamp":1746126286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365914000510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":45,"alternative-id":["S0168365914000510"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.01.022","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon gamma peptidomimetic targeted to hepatic stellate cells ameliorates acute and chronic liver fibrosis in vivo","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}